Related Experiment Video
Updated: Jul 12, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Molecular characterization of cell dynamics during osteosarcoma progression.
Xiangjie Li1, Junjie Liu1, Yu Wang1
1Wuxi School of Medicine, Jiangnan University, Wuxi, 214000, PR China; Department of Orthopedics, Affiliated Hospital of Jiangnan University, Wuxi, 214000, PR China.
Translational Oncology
|July 9, 2026
Summary
Osteosarcoma metastasis involves significant microenvironment remodeling, with altered cell proportions and immune cell reprogramming. This study provides a comprehensive view of cellular changes during osteosarcoma progression.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Osteosarcoma is a common bone cancer with high heterogeneity and complex metastatic processes.
- Current treatments face challenges due to tumor heterogeneity and dynamic cellular changes during metastasis.
Purpose of the Study:
- To systematically analyze cellular composition and microenvironment dynamics during osteosarcoma progression from primary to metastatic stages.
- To integrate multi-center single-cell and spatial transcriptomics data for a comprehensive understanding of osteosarcoma evolution.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) with SingleR for cell annotation and subcluster analysis.
- Pseudotime analysis using Monocle2 and scTour to construct cell differentiation trajectories.
- Spatial transcriptomics deconvolution with CARD to analyze cell distribution.
Main Results:
- Metastatic osteosarcoma shows significant microenvironment remodeling: increased fibroblasts, mast cells, T/NK cells; decreased osteoblasts, myeloid cells.
- Identified YY1 as a spatial regulator of IER5L in subtype 2, linked to divergent evolutionary paths.
- Observed immune and stromal cell reprogramming, including functional transformation of tumor-associated macrophages (TAMs) in metastatic foci.
Conclusions:
- This study represents a large-scale integration of multi-center data covering primary, recurrent, and metastatic osteosarcoma.
- It systematically depicts dynamic cellular changes, offering insights into osteosarcoma progression and metastasis.
- Findings highlight the potential for novel therapeutic strategies targeting the evolving tumor microenvironment.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...